Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease) (GENKYST)

September 1, 2016 updated by: University Hospital, Brest
Genkyst is a regional cohort involving up to nephrologists working in private and public nephrology centers in the West of France. It registers clinical and molecular genetic data of all consenting patients with ADPKD from this area.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

4000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Angers, France, 49933
        • Recruiting
        • CHU Angers
        • Contact:
        • Principal Investigator:
          • Jean Francois Augusto, MD PhD
      • Brest, France, 29200
        • Recruiting
        • CHU Brest
      • Brest, France, 29200
        • Recruiting
        • AUB Brest
        • Contact:
          • Marie-Paule GUILLODO-HAMELET
      • Brest, France, 29283
        • Recruiting
        • Centre Nephrologie et Dialyse d Armorique
        • Contact:
        • Principal Investigator:
          • Katell Goulesque, MD
      • La Roche sur Yon, France, 85925
      • Le Mans, France, 72037
        • Recruiting
        • CH Le Mans
        • Contact:
        • Principal Investigator:
          • Jean Philippe Coindre, MD
      • Le Mans, France, 72016
        • Recruiting
        • ECHO dialyse
        • Contact:
        • Principal Investigator:
          • Guillaume Seret, MD
      • Lorient, France, 56100
        • Recruiting
        • AUB Lorient
        • Contact:
          • Didier Legrand, MD
        • Principal Investigator:
          • Didier Legrand, MD
      • Lorient, France, 56322
      • Morlaix, France, 29600
        • Recruiting
        • AUB Morlaix
        • Contact:
        • Principal Investigator:
          • Marin Le Mee, MD
      • Nantes, France, 44093
        • Recruiting
        • CHU Nantes
        • Contact:
          • Maryvonne Hourmand, MD PhD
        • Principal Investigator:
          • Maryvonne Hourmand, MD PhD
      • Niort, France, 79021
        • Recruiting
        • CH Niort
        • Contact:
          • Delphine LABATUT, PH
      • Poitiers, France, 86021
      • Pontivy, France, 56300
      • Quimper, France, 29107
      • Quimper, France, 29107
        • Recruiting
        • CHI de Cournouaille
        • Contact:
        • Principal Investigator:
          • Bassem Wehbe, MD
      • Rennes, France, 35033
        • Recruiting
        • CHU Rennes
      • Reze, France, 44402
        • Recruiting
        • ECHO Confluent
        • Contact:
        • Principal Investigator:
          • Angelo Testa, MD
      • Roscoff, France, 29684
        • Recruiting
        • Centre Heliomarin de Roscoff
        • Contact:
        • Principal Investigator:
          • Sonia Mzoughi, MD
      • Saint Brieuc, France, 22023
      • Saint Herblain, France, 44821
        • Recruiting
        • ECHO Centre Ambulatoire
        • Contact:
          • Corneliu Savoiu, MD
        • Principal Investigator:
          • Corneliu Savoiu, MD
      • Saint Malo, France, 35403
        • Recruiting
        • CH Saint Malo
        • Contact:
          • Eric Renaudineau, MD
        • Principal Investigator:
          • Eric Renaudineau, MD
      • Saint Nazaire, France, 44606
        • Recruiting
        • CH de Saint Nazaire
        • Contact:
          • Dominique Besnier, MD
        • Principal Investigator:
          • Dominique Besnier, MD
      • Tours, France, 37044
        • Recruiting
        • Chu Tours
        • Contact:
        • Principal Investigator:
          • Mathias Buchler, MD PhD
      • Vannes, France, 56017
      • Vannes, France, 56017
        • Recruiting
        • ECHO Vannes
        • Contact:
        • Principal Investigator:
          • Victorio Menoyo, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

ADPKD patients followed in Nephrology centers in the West of France

Description

Inclusion Criteria:

  • ADPKD patients followed in Nephrology centers in the West of France
  • Age >17

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Clinical description of the patient
Time Frame: at the inclusion day
at the inclusion day

Secondary Outcome Measures

Outcome Measure
Time Frame
Genetic analysis
Time Frame: at the inclusion day
at the inclusion day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Brest

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (ANTICIPATED)

January 1, 2020

Study Registration Dates

First Submitted

August 30, 2016

First Submitted That Met QC Criteria

September 1, 2016

First Posted (ESTIMATE)

September 2, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

September 2, 2016

Last Update Submitted That Met QC Criteria

September 1, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GENKYST

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autosomal Dominant Polycystic Kidney Disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe